Introduction
============

Carney complex (CNC) is an autosomal dominant multiple neoplasia syndrome involving skin and cardiac myxomas, pigmented skin lesions and endocrine tumors. About 700 patients worldwide have been reported by the National Institutes of Health, Mayo Clinic (USA) and the Institut Cochin (France) by January 2008 \[[@B1]\]. Cardiac myxomas are the second most common manifestations of CNC after skin lentigines \[[@B2]\]. Among all cardiac myxomas, left atrial cardiac myxomas are the most common (75%) \[[@B3],[@B4]\], followed by right atrial (18%), with left and right ventricular myxomas being the least common (2.5 to 4%) \[[@B5]-[@B7]\]. Nearly 7% of all cardiac myxomas are associated with CNC. Various locations of cardiac myxomas associated with CNC have been reported so far but none originating in the right ventricle. We are reporting a case of recurrent cardiac myxoma of the right side of the heart which recurred 2 years after the initial presentation with simultaneous pituitary microadenoma and skin lentigines consistent with the diagnosis of CNC.

Case presentation
=================

A 46-year-old Caucasian man recently diagnosed with benign thyroid hyperplasia presented to his primary care physician with palpitations, light-headedness, and dizziness and was found to be in atrial fibrillation with rapid heart rate of 140 beats per minute. He denied chest pain, shortness of breath, fevers, night sweats, weight loss, and fatigue. His heart rate was controlled and a transthoracic echocardiogram (TTE) was obtained which showed a right ventricular mass attached to his interventricular septum that was confirmed on a subsequent transesophageal echocardiogram (Figure [1](#F1){ref-type="fig"}A, [1](#F1){ref-type="fig"}B, [1](#F1){ref-type="fig"}C) \[Additional file [1](#S1){ref-type="supplementary-material"}: Movies 1 and 2\]. Cardiac magnetic resonance imaging (MRI) showed a 2.5cm soft tissue density in his right ventricle attached to the mid-septum (Figure [2](#F2){ref-type="fig"}A, [2](#F2){ref-type="fig"}B, [2](#F2){ref-type="fig"}C).

![**Transthoracic and transesophageal echocardiograms. (A, B)** Parasternal long and short axis views showing right ventricular mass (marked with red arrow). **C**: Transesophageal echocardiogram: Five chamber view, showing right ventricular mass attached with a stalk to interventricular septum (red arrow).](1752-1947-8-134-1){#F1}

![**Magnetic resonance imaging. (A, B)** Magnetic resonance imaging perfusion imaging showing right ventricular mass extending from the base of the right ventricle to the apex (red arrow). **C**: Magnetic resonance imaging pre-scan (pre-perfusion) images showing right ventricular mass (red arrow).](1752-1947-8-134-2){#F2}

A surface echocardiogram was performed intraoperatively \[Additional file [2](#S2){ref-type="supplementary-material"}: Movie 3\] and surgical resection of the right ventricular mass was performed followed by the Maze procedure. The resected mass was bilobed measuring at least 7cm×1.5cm (Figure [3](#F3){ref-type="fig"}A, [3](#F3){ref-type="fig"}B). Pathology confirmed a myxoma (Figure [4](#F4){ref-type="fig"}A, [4](#F4){ref-type="fig"}B, [4](#F4){ref-type="fig"}C, [4](#F4){ref-type="fig"}D). Brownish macules were noted on the patient's lips, conjunctivae and all over his body. Considering his examination findings, cardiac myxoma and history of thyroid neoplasm, concern for a genetic syndrome was raised. He denied any known family history of similar examination findings or known hereditary diseases. At that time he did not pursue genetic screening and was followed regularly with yearly TTE.

![**Intra- operative pictures. A:** A right ventricular myxoma seen through the tricuspid valve intraoperatively. **B**: Right ventricular mass attached to the base of the right ventricle. **C**: Small resected mass at the apex of right atrium.](1752-1947-8-134-3){#F3}

![**Histopathology. A**: Hematoxylin and eosin stain showing scattered single myxoma cells, stellate and plump, in a background of amorphous; basophilic material admixed with fibrillary pink stroma. **B**: Hematoxylin and eosin stain showing myxoma cells forming rings, cords and nests. **C**: Hematoxylin and eosin stain showing heterologous bone within tumor. **D**: Hematoxylin and eosin stain showing heterologous smooth muscle elements within the tumor.](1752-1947-8-134-4){#F4}

Screening with TTE 2 years later revealed a new mass in his right atrium measuring 1.8cm×1.4cm on resection and it was a myxoma (Figure [3](#F3){ref-type="fig"}C). He underwent rigorous workup for CNC which revealed elevated insulin-like growth factor 1 (IGF-1) levels, and positive oral glucose tolerance test with pituitary microadenoma on MRI consistent with acromegaly. He was also diagnosed with bilateral multiple large-cell calcifying Sertoli cell tumor (LCCSCT) of the testes. He was treated for acromegaly and was also recommended to follow up with repeat pituitary MRI in 6 months and an annual testicular ultrasonography. His children were sent for genetic studies.

Discussion
==========

The CNC was first described in 1985 by J. Aidan Carney, as the combination of myxomas, spotty pigmentation and endocrine overactivity \[[@B8]\]. CNC is defined as an autosomal dominant, multiple neoplasia syndrome involving skin and cardiac myxomas, pigmented skin lesions and endocrine tumors.

The most recent diagnostic criteria include clinical findings such as spotty skin pigmentation, cutaneous and cardiac myxomas, breast myxomatosis, acromegaly, primary pigmented nodular adrenocortical disease, blue nevus, epithelioid blue nevus, osteochondromyxoma, thyroid carcinoma, LCCSCT in males, ovarian cyst in females and mutation of the *PRKAR1A* gene. At least two of these manifestations must be present to confirm the diagnosis of CNC. With *PRKAR1A* mutation and/or a first-degree relative affected by CNC, a single manifestation is sufficient for the diagnosis \[[@B8]-[@B11]\].

Cardiac myxomas are rare benign tumors accounting for 45% of primary cardiac tumors in adults \[[@B12]\] and among cardiac myxomas, left atrial cardiac myxomas are the most common (75%) followed by right atrial (18%), followed by left and right ventricular myxomas being the least common (2.5 to 4%). Up to 7% of all the cardiac myxomas are associated with CNC and are notorious for recurrence \[[@B13]\] when compared to sporadic cardiac myxomas. CNC cardiac myxomas are known to have a left heart origin and are unlikely to be right sided as in our patient. Patients with CNC who have cardiac tumors may be totally asymptomatic but have an increased risk of sudden death, which makes it clinically important.

CNC is associated with at least two genetic loci including the *PRKAR1A* gene located on chromosome 17 and the *CNC2* locus mapped to chromosome 2 \[[@B14]\] and a possible third loci. Clinical suspicion of CNC should be followed by thorough evaluation. This includes biochemical and imaging modalities for endocrine, cardiac and skin tumors. A preoperative coronary angiograph is advised if coronary artery disease is suspected or if the patient is above the age of 40 years \[[@B15]\]. Surgical excision of the tumors is the primary management of most tumors \[[@B16]\].

Due to its high association with morbidity and mortality, surveillance is key. For pre-pubertal, post-pubertal children and adults with excised myxoma, an echocardiogram is performed every 6 months or yearly. For children with LCCSCT, close monitoring of growth rate, pubertal status and testicular ultrasonography are essential. Every patient diagnosed with CNC should have a yearly testicular ultrasound, and serum IGF-1 levels and urinary free cortisol levels should be monitored. Thyroid ultrasound and ovarian ultrasound should be repeated as needed \[[@B17]\]. Approximately 70% of individuals diagnosed with CNC have an affected parent; approximately 30% have a *de novo* mutation \[[@B1]\]; first degree relatives should be screened when *PRKAR1A* mutations are identified.

Conclusions
===========

Our patient initially had multiple myxomas in his right ventricle, the least common location of cardiac myxomas, which aroused the suspicion of CNC and reevaluation confirmed the diagnosis. This is the first case of right ventricular cardiac myxoma in association with CNC.
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**Movie 1 and 2.** Transthoracic echocardiogram and transesophageal echocardiogram showing right ventricle mass.
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**Movie 3.** Surface echocardiogram in the operating room reveals bilobed right ventricular mass.
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